Spots Global Cancer Trial Database for ferritin
Every month we try and update this database with for ferritin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome | NCT01892644 | Hemochromatosis Myelodysplastic... | Deferasirox Venesection Deferasirox | 18 Years - 80 Years | Haukeland University Hospital | |
This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload. | NCT01250951 | Myelodysplastic... Thalassemia | Deferasirox | 2 Years - | Novartis | |
Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism,in Malignant Breast Diseases | NCT00539422 | Breast Cancer | pcr and serum m... | 33 Years - 63 Years | Mansoura University | |
Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome | NCT01892644 | Hemochromatosis Myelodysplastic... | Deferasirox Venesection Deferasirox | 18 Years - 80 Years | Haukeland University Hospital | |
Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome | NCT01892644 | Hemochromatosis Myelodysplastic... | Deferasirox Venesection Deferasirox | 18 Years - 80 Years | Haukeland University Hospital | |
Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism,in Malignant Breast Diseases | NCT00539422 | Breast Cancer | pcr and serum m... | 33 Years - 63 Years | Mansoura University |